곽혜선(郭惠善) 교수

약학과[대학원] /약학부 /제약산업학과[대학원]

곽혜선 프로필 사진
곽혜선 교수는 미국 아이오와 대학에서 팜디를 받았고 약학대학에서 순환계, 내분비계 및 위장관계 약물치료학을 가르치고 있다. 심장판막치환 환자에서의 와파린 사용과 조기수축을 앓고 있는 임산부에서의 조기수축억제제들을 대상으로 관련유전자의 단일염기서열의 변이에 따른 약물동태와 동력의 변화를 규명하는 연구 이외에 최근에는 직접 경구용 항응고제의 효과 및 안전성 관련 유전체 연구 및 기계학습 활용 위험점수 확립 등의 연구를 진행하고 있다. 한국임상약학회 회장을 맡고 있으며 현재까지 약 150 여편의 SCI급 논문을 포함 총 200 여편의 논문을 게재하였다. 저서로는 『약물치료학』, 『기초약무실습』, 『처방조제와 복약지도』가 있다.
  • 임상바이오헬스대학원장/임상보건융합대학원장/약학대학장/PHC센터소장/제약바이오융합교육센터소장
  • 약학관 B동 103호
  • 02-3277-4376
  • 면담 가능시간
    • 수 3시30분-5시, 금10-12시
연구실적
  • Sleep-related adverse events of smoking cessation drugs: A network meta-analysis of randomized controlled trials Psychiatry Research, 2024, v.335, 115874
    SCIE SSCI Scopus dColl.
  • ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, v.17, 2513-2522
    SCIE Scopus dColl.
  • Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban Scientific Reports, 2023, v.13 no.1, 15967
    SCIE Scopus dColl.
  • Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, v.52 no.7, 340-347
    SCIE Scopus dColl.
  • Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States FRONTIERS IN PHARMACOLOGY, 2023, v.14, 1205624
    SCIE Scopus dColl.
  • Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants FRONTIERS IN PHARMACOLOGY, 2023, v.14, 1290785
    SCIE Scopus dColl.
  • Correlation between PPARG Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis Pharmaceutics, 2023, v.15 no.6, 1778
    SCIE Scopus dColl.
  • Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis FRONTIERS IN PHARMACOLOGY, 2023, v.14, 1201083
    SCIE Scopus dColl.
  • Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients MEDICINA-LITHUANIA, 2023, v.59 no.2, 292
    SCIE Scopus dColl.
  • Interactive Associations between PPARγ and PPARGC1A and Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis Pharmaceuticals, 2023, v.16 no.7, 1035
    SCIE Scopus dColl.
  • Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case–control study Hormones, 2023, v.22 no.4, 637-645
    SCIE Scopus dColl.
  • Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study Biomedicines, 2023, v.11 no.8, 2308
    SCIE Scopus dColl.
  • Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information FRONTIERS IN MEDICINE, 2023, v.10, 1140620
    SCIE Scopus dColl.
  • Risk Factors for Palbociclib-Induced Early Developing Neutropenia in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Cancers, 2023, v.15 no.10, 2810
    SCIE Scopus dColl.
  • A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors Frontiers in Oncology, 2022, v.12, 790343
    SCIE Scopus dColl.
  • Antihypertensive drug use and psoriasis: A systematic review, meta- and network meta-analysis British Journal of Clinical Pharmacology, 2022, v.88 no.3, 933-941
    SCIE Scopus dColl.
  • Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants Pharmaceutics, 2022, v.14 no.9, 1889
    SCIE Scopus dColl.
  • Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis ANTI-CANCER DRUGS, 2022, v.33 no.1, 75-79
    SCIE Scopus dColl.
  • Association of P450 Oxidoreductase Gene Polymorphism with Tacrolimus Pharmacokinetics in Renal Transplant Recipients: A Systematic Review and Meta-Analysis PHARMACEUTICS, 2022, v.14 no.2, 261
    SCIE Scopus dColl.
  • Associations of GNAS and RGS Gene Polymorphisms with the Risk of Ritodrine-Induced Adverse Events in Korean Women with Preterm Labor: A Cohort Study Pharmaceutics, 2022, v.14 no.6, 1220
    SCIE Scopus dColl.
  • Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis Pharmaceuticals, 2022, v.15 no.4, 416
    SCIE Scopus dColl.
  • Effects of CYP2D6 genotypes on Plasmodium vivax recurrence after primaquine treatment: A meta-analysis Travel Medicine and Infectious Disease, 2022, v.48, 102333
    SCIE Scopus dColl.
  • Genetic Factors of Renin-Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants PHARMACEUTICS, 2022, v.14 no.2, 231
    SCIE Scopus dColl.
  • Global Research Trends of Gender-Related Artificial Intelligence in Medicine Between 2001–2020: A Bibliometric Study Frontiers in Medicine, 2022, v.9, 868040
    SCIE Scopus dColl.
  • Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study British Journal of Clinical Pharmacology, 2022, v.88 no.6, 2738-2746
    SCIE Scopus dColl.
  • Risk Scoring System for Vancomycin-Associated Acute Kidney Injury Frontiers in Pharmacology, 2022, v.13, 815188
    SCIE Scopus dColl.
  • Risk factors for vancomycin-associated acute kidney injury: A systematic review and meta-analysis British Journal of Clinical Pharmacology, 2022
    SCIE Scopus dColl.
  • The Association between ABCG2 421C>A (rs2231142) Polymorphism and Rosuvastatin Pharmacokinetics: A Systematic Review and Meta-Analysis Pharmaceutics, 2022, v.14 no.3, 501
    SCIE Scopus dColl.
  • A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence Scientific Reports, 2021, v.11 no.1, 10037
    SCIE Scopus dColl.
  • ABCA1 69C>T Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Systematic Review and Updated Meta-Analysis Frontiers in Endocrinology, 2021, v.12, 639524
    SCIE Scopus dColl.
  • Analysis of risk factors for hepatotoxicity induced by immune checkpoint inhibitors Journal of Immunotherapy, 2021 , 16-21
    SCIE Scopus dColl.
  • Article machine learning approaches to predict hepatotoxicity risk in patients receiving nilotinib Molecules, 2021, v.26 no.11, 3300
    SCIE Scopus dColl.
  • Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis CLINICAL THERAPEUTICS, 2021, v.43 no.5, 836-
    SCIE Scopus dColl.
  • Association between ABCA1 Gene Polymorphisms and Plasma Lipid Concentration: A Systematic Review and Meta-Analysis JOURNAL OF PERSONALIZED MEDICINE, 2021, v.11 no.9, 883
    SCIE Scopus dColl.
  • Association between ADCY9 Gene Polymorphisms and Ritodrine Treatment Outcomes in Patients with Preterm Labor PHARMACEUTICS, 2021, v.13 no.10, 1653
    SCIE Scopus dColl.
  • Association between CYP3A5 Polymorphism and Statin-Induced Adverse Events: A Systemic Review and Meta-Analysis JOURNAL OF PERSONALIZED MEDICINE, 2021, v.11 no.7, 677
    SCIE Scopus dColl.
  • Association between attention deficit hyperactivity disorder and aggression subscales in adolescents Brain and Behavior, 2021, v.11 no.3
    SCIE Scopus dColl.
  • Association between statin use and sensorineural hearing loss in type 2 diabetic patients: A hospital-based study Pharmaceuticals, 2021, v.14 no.11, 1076
    SCIE Scopus dColl.
  • Effects of Ephedrine-Containing Products on Weight Loss and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials PHARMACEUTICALS, 2021, v.14 no.11, 1198
    SCIE Scopus dColl.
  • Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers JOURNAL OF PERSONALIZED MEDICINE, 2021, v.11 no.9, 862
    SCIE Scopus dColl.
  • Gene Polymorphisms of the Renin-Angiotensin System and Bleeding Complications of Warfarin: Genetic-Based Machine Learning Models PHARMACEUTICALS, 2021, v.14 no.8, 824
    SCIE Scopus dColl.
  • Influence of C Upsilon P2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis JOURNAL OF PERSONALIZED MEDICINE, 2021, v.11 no.7, 617
    SCIE Scopus dColl.
  • Machine learning approaches for predicting bisphosphonate-related osteonecrosis in women with osteoporosis using vegfa gene polymorphisms Journal of Personalized Medicine, 2021, v.11 no.6, 541
    SCIE Scopus dColl.
  • Risk Scoring System of Mortality and Prediction Model of Hospital Stay for Critically Ill Patients Receiving Parenteral Nutrition HEALTHCARE, 2021, v.9 no.7, 853
    SCIE SSCI Scopus dColl.
  • Short-term exposure to air pollution and hospital admission for pneumonia: a systematic review and meta-analysis Environmental Health: A Global Access Science Source, 2021 , 6
    SCIE Scopus dColl.
  • Smartphone Addiction and Anxiety in Adolescents - A Cross-sectional Study AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2021, v.45 no.5, 895-901
    SSCI dColl.
  • TGF-β1 polymorphism increases the risk of bleeding complications in patients on oral anticoagulant after cardiac valve replacement Heart and Vessels, 2021, v.36 no.12, 1885-1891
    SCIE Scopus dColl.
  • 국내 허가사항에 반영된 약물 유전정보 분석 한국임상약학회지, 2021, v.31 no.1, 21-26
    KCI dColl.
  • Association Between Glutathione-S-Transferase Gene Polymorphisms and Responses to Tyrosine Kinase Inhibitor Treatment in Patients with Chronic Myeloid Leukemia: A Meta-analysis TARGETED ONCOLOGY, 2020, v.15 no.1, 47-54
    SCIE Scopus dColl.
  • Association between preoperative use of antithrombotic medications and intraoperative transfusion in older patients undergoing cancer surgery ASIAN JOURNAL OF SURGERY, 2020, v.43 no.5, 585-592
    SCIE Scopus dColl.
  • Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment AMERICAN JOURNAL OF SURGERY, 2020, v.219 no.6, 963-968
    SCIE Scopus dColl.
  • Clinical and Laboratory Features of Pediatric Patients with COVID-19: Systematic Review and Meta-analysis 한국임상약학회지, 2020, v.30 no.4, 270-278
    KCI dColl.
  • Clinical manifestations and perinatal outcomes of pregnant women with COVID-19: a systematic review and meta-analysis Scientific Reports, 2020, v.10 no.1, 18126
    SCIE Scopus dColl.
  • Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis Scientific Reports, 2020, v.10 no.1, 17390
    SCIE Scopus dColl.
  • Effects of Citrulline Supplementation on Body Weight in Patients With Hepatobiliary Pancreatic Surgery Nutrition in Clinical Practice, 2020, v.35 no.2, 323-330
    SCIE Scopus dColl.
  • Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, v.8 no.5, e1201
    SCIE Scopus dColl.
  • Effects of pharmacist interventions on reducing prescribing errors of investigational drugs in oncology clinical trials JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, v.26 no.1, 29-35
    SCIE Scopus dColl.
  • Effects ofKCNMB2gene polymorphisms on ritodrine therapy outcomes in women with preterm labor PHARMACOGENETICS AND GENOMICS, 2020, v.30 no.6, 124-130
    SCIE Scopus dColl.
  • Efficacy and safety of clopidogrel versus prasugrel and ticagrelor for coronary artery disease treatment in patients with CYP2C19 LoF alleles: a systemic review and meta-analysis British Journal of Clinical Pharmacology, 2020, v.86 no.8, 1489-1498
    SCIE Scopus dColl.
  • Factors Associated With Voriconazole Concentration in Pediatric Patients Therapeutic drug monitoring, 2020, v.42 no.6, 866-871
    SCIE Scopus dColl.
  • Factors Influencing Imatinib-Induced Hepatotoxicity CANCER RESEARCH AND TREATMENT, 2020, v.52 no.1, 181-188
    SCIE Scopus KCI dColl.
  • Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study European Journal of Clinical Pharmacology, 2020, v.76 no.8, 1183-1191
    SCIE Scopus dColl.
  • Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study Scientific Reports, 2020, v.10 no.1, 6988
    SCIE Scopus dColl.
  • Health Behaviors Associated with Aggression in Korean Adolescents: Data from 2 Cross-sectional Studies AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2020, v.44 no.2, 271-282
    SSCI dColl.
  • Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis European Journal of Clinical Pharmacology, 2020, v.76 no.8, 1053-1058
    SCIE Scopus dColl.
  • Influence of GRK5 gene polymorphisms on ritodrine efficacy and adverse drug events in preterm labor treatment Scientific Reports, 2020, v.10 no.1, 1351
    SCIE Scopus dColl.
  • Low cyclosporine concentrations in children and time to acute graft versus host disease BMC PEDIATRICS, 2020, v.20 no.1
    SCIE Scopus dColl.
  • Population Pharmacokinetics of Sulindac and Genetic Polymorphisms of FMO3 and AOX1 in Women with Preterm Labor Pharmaceutical Research, 2020, v.37 no.3, 44
    SCIE Scopus dColl.
  • Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan European Journal of Clinical Pharmacology, 2020, v.76 no.5, 723-729
    SCIE Scopus dColl.
  • The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis Scientific Reports, 2020, v.10 no.1, 3658
    SCIE Scopus dColl.
  • The impact of drug interactions on adverse effects of oral oxycodone in male geriatric patients Journal of Clinical Pharmacy and Therapeutics, 2020, v.45 no.5, 976-982
    SCIE Scopus dColl.
  • Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2020, v.27 no.E1, E25-E29
    SCIE Scopus dColl.
  • APOB gene polymorphisms may affect the risk of minor or minimal bleeding complications in patients on warfarin maintaining therapeutic INR EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, v.27 no.10, 1542-1549
    SCIE Scopus dColl.
  • Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio Pharmacogenetics and genomics, 2019, v.29 no.8, 200-206
    Scopus dColl.
  • Association between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio PHARMACOGENOMICS, 2019, v.20 no.9, 659-667
    SCIE Scopus dColl.
  • Association between anxiety and aggression in adolescents: a cross-sectional study BMC PEDIATRICS, 2019, v.19, 115
    SCIE Scopus dColl.
  • Comparisons of doxycycline solution with talc slurry for chemical pleurodesis and risk factors for recurrence in South Korean patients with spontaneous pneumothorax EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2019, v.26 no.5, 275-279
    SCIE Scopus dColl.
  • Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study British Journal of Clinical Pharmacology, 2019, v.85 no.8, 1719-1727
    SCIE Scopus dColl.
  • Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, v.105 no.6, 1477-1491
    SCIE Scopus dColl.
  • Effects of PDE4 gene polymorphisms on efficacy and adverse drug events of ritodrine therapy in preterm labor patients: a prospective observational study EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, v.75 no.10, 1379-1386
    SCIE Scopus dColl.
  • Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses CARDIOVASCULAR THERAPEUTICS, 2019 , 1813747
    SCIE Scopus dColl.
  • Effects of cyclic parenteral nutrition on parenteral nutrition-associated cholestasis in newborns ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2019, v.28 no.1, 42-48
    SCIE Scopus dColl.
  • Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study Journal of Gastroenterology, 2019, v.54 no.12, 1052-1060
    SCIE Scopus dColl.
  • Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, v.13, 1717-1727
    SCIE Scopus dColl.
  • Risk factors associated with the incidence and time to onset of lapatinib-induced hepatotoxicity Breast Cancer Research and Treatment, 2019, v.178 no.1, 239-244
    SCIE Scopus dColl.
  • Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim Asia-Pacific Journal of Clinical Oncology, 2019, v.15 no.4, 231-237
    SCIE Scopus dColl.
  • 암 환자에서의 임상시험용 의약품 처방 오류 분석 병원약사회지, 2019, v.36 no.3, 366~373
    KCI dColl.
  • Association between MKRN3 and LIN28B polymorphisms and precocious puberty BMC Genetics, 2018, v.19 no.1, 47
    SCIE Scopus dColl.
  • Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, v.30 no.10, 1177-1185
    SCIE Scopus dColl.
  • Effects of Concomitant Medication Use on Gefitinib-Induced Hepatotoxicity JOURNAL OF CLINICAL PHARMACOLOGY, 2018, v.58 no.2, 263-268
    SCIE Scopus dColl.
  • Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients Medical Oncology, 2018, v.35 no.12, 154
    SCIE Scopus dColl.
  • Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity ANTI-CANCER DRUGS, 2018, v.29 no.5, 471-476
    SCIE Scopus dColl.
  • Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses GENE, 2018, v.641, 68-73
    SCIE Scopus dColl.
  • Preoperative medication use and its association with postoperative length of hospital stay in surgical oncology patients receiving comprehensive geriatric assessment GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, v.18 no.1, 12-19
    SCIE SSCI dColl.
  • Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study BMC CANCER, 2018, v.18, 988
    SCIE Scopus dColl.
  • Risk factors of opioid-induced adverse reactions in elderly male outpatients of Korea Veterans Hospital BMC GERIATRICS, 2018, v.18, 293
    SCIE SSCI Scopus dColl.
  • Smartphone addiction risk and daytime sleepiness in Korean adolescents JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, v.54 no.7, 800-806
    SCIE Scopus dColl.
  • 조혈모세포 이식을 받은 소아 환자에서 cyclosporine의 집단 약동학 분석 한국임상약학회지, 2018, v.28 no.1, 24~29
    KCI dColl.
  • Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients European Journal of Clinical Pharmacology, 2017, v.73 n.7, 1-6
    SCIE Scopus dColl.
  • Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: A prospective observational study BMC Genetics, 2017, v.18 no.1
    SCIE Scopus dColl.
  • Attitudes to proposed assessment of pharmacy skills in Korean pharmacist licensure examination Journal of educational evaluation for health professions, 2017, v.14, 6
    Scopus dColl.
  • Effects of adrenal androgen levels on bone age advancement in prepubertal children: Using the Ewha birth and growth cohort study Journal of Korean Medical Science, 2017, v.32 no.6, 968-973
    SCIE Scopus KCI dColl.
  • Elevated Metabolites of Steroidogenesis and Amino Acid Metabolism in Preadolescent Female Children With High Urinary Bisphenol A Levels: A High-Resolution Metabolomics Study TOXICOLOGICAL SCIENCES, 2017, v.160 no.2, 371-385
    SCIE Scopus dColl.
  • Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients Medical Oncology, 2017, v.34 no.12, 199
    SCIE Scopus dColl.
  • Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, v.236, 393-397
    SCIE Scopus dColl.
  • New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism BIOMOLECULES & THERAPEUTICS, 2017, v.25 no.5, 461-470
    SCIE Scopus KCI dColl.
  • Outcomes with perioperative fat emulsions containing omega-3 fatty acid: A meta-analysis of randomized controlled trials American Journal of Health-System Pharmacy, 2017, v.74 no.12, 904-918
    SCIE Scopus dColl.
  • 제 2형 당뇨병 환자에서 Metformin과 병용 시 Dapagliflozin과 Sitagliptin의 효능 비교 한국임상약학회지, 2017, v.27 no.2, 99~104
    KCI dColl.
  • Association of inflammatory gene polymorphisms with mechanical heart valve reoperation SPRINGERPLUS, 2016, v.5
    SCIE Scopus dColl.
  • Association of pre-operative medication use with post-operative delirium in surgical oncology patients receiving comprehensive geriatric assessment BMC GERIATRICS, 2016, v.16
    SCIE SSCI Scopus dColl.
  • Evaluation of the predictors of readmission in Korean patients with heart failure Journal of Clinical Pharmacy and Therapeutics, 2016, v.42 no.1
    SCIE Scopus dColl.
  • 암환자의 정맥혈전색전증 치료에서 rivaroxaban과 dalteparin의 출혈 부작용 비교 한국임상약학회지, 2016, v.26 no.3, 195~200
    KCI dColl.
  • Application of Monodirectional Janus Patch to Oromucosal Delivery System Advanced Healthcare Materials, 2015, 8 SEP 2015
    SCIE Scopus dColl.
  • Association of inflammatory gene polymorphisms with the prosthetic heart valve reoperation PHARMACOTHERAPY, 2015, v.35 no.11, E178-E178
    SCIE Scopus dColl.
  • Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves European Journal of Clinical Pharmacology, 2015, v.71 no.10, 1229-1236
    SCIE Scopus dColl.
  • Effects of pregnane X receptor genetic polymorphisms on stable warfarin doses Journal of Cardiovascular Pharmacology and Therapeutics, 2015, v.20 no.6, 532-538
    SCIE Scopus dColl.
  • Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements PHARMACOGENOMICS, 2015, v.16 no.10, 1101-1108
    SCIE Scopus dColl.
  • INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation International Journal of Clinical Pharmacy, 2015, 12 Jun 2015
    Scopus dColl.
  • Impact of GATA4 variants on stable warfarin doses in patients with prosthetic heart valves PHARMACOGENOMICS JOURNAL, 2015, v.15 no.1, 33-37
    SCIE Scopus dColl.
  • Impact of NQO1 variants on stable warfarin doses in Korean patients with mechanical cardiac valves PHARMACOTHERAPY, 2015, v.35 no.11, E206-E207
    SCIE Scopus dColl.
  • Impact of pediatric pharmacist interventions in general pediatric ward in Korea PHARMACOTHERAPY, 2015, v.35 no.11, E251-E251
    SCIE Scopus dColl.
  • Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves Cardiovascular Therapeutics, 2015, v.33 no.6, 324-328
    SCIE Scopus dColl.
  • Influence of UDP-glucuronosyltransferase polymorphisms on warfarin dosing requirement PHARMACOTHERAPY, 2015, v.35 no.11, E207-E207
    SCIE Scopus dColl.
  • Relationship of serum 25-Hydroxyvitamin D (25[OH]D) levels and components of metabolic syndrome in prepubertal children Nutrition, 2015, v.31 no.42320, 1324-1327
    SCIE Scopus dColl.
  • The preventive effect of breast-feeding for longer than 6 months on early pubertal development among children aged 7-9 years in Korea Public Health Nutrition, 2015, v.18 no.18, 3300-3307
    SCIE Scopus dColl.
  • 제2형 당뇨병 환자에서 Metformin/Dipeptidyl Peptidase-4 저해제 병용요법과Metformin/Sulfonylurea 병용요법간의 효과에 대한 비교 연구 한국임상약학회지, 2015, v.25 no.2, 74-79
    KCI dColl.
  • 6년제 약대 학제시스템 만족도에 영향을 미치는 요인 분석 및 향후 전략 한국임상약학회지, 2014, 제24권 4호, 288-295
    KCI dColl.
  • Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, v.39 no.3, 314-318
    SCIE Scopus dColl.
  • Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses Pharmacogenetics and Genomics, 2014, v.25 no.1, 38-40
    SCIE Scopus dColl.
  • Development of clinical pharmacy services for intensive care units in Korea SpringerPlus, 2014, v.3 no.1, 1-7
    SCIE Scopus dColl.
  • EFFECT OF BIOCOMPATIBLE PERITONEAL DIALYSIS SOLUTION ON RESIDUAL RENAL FUNCTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS PERITONEAL DIALYSIS INTERNATIONAL, 2014, v.34 no.7, 724-731
    SCIE Scopus dColl.
  • Effects of Single-Nucleotide Polymorphisms of FMO3 and FMO6 Genes on Pharmacokinetic Characteristics of Sulindac Sulfide in Premature Labor DRUG METABOLISM AND DISPOSITION, 2014, v.42 no.1, 40-43
    SCIE Scopus dColl.
  • Effects of inflammatory cytokine gene polymorphisms on warfarin maintenance doses in Korean patients with mechanical cardiac valves ARCHIVES OF PHARMACAL RESEARCH, 2014, v.37 no.6, 752-759
    SCIE KCI Scopus dColl.
  • Effects of β2-adrenergic receptor gene polymorphisms on ritodrine therapy in pregnant women with preterm labor: Prospective follow-up study International Journal of Molecular Sciences, 2014, v.15 no.7, 12885-12894
    SCIE Scopus dColl.
  • Outcomes of a new dosage regimen of amikacin based on pharmacokinetic parameters of Korean neonates AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, v.71 no.2, 122-127
    SCIE Scopus dColl.
  • Pharmacokinetic evaluation of formulated levodopa methyl ester nasal delivery systems EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2014, v.39 no.4, 237-242
    SCIE Scopus dColl.
  • 고등학생의 공격적 성향과 건강 행태에 관한 연구 한국임상약학회지, 2014, 제24권 2호, 144-153
    KCI dColl.
  • 습기주의 약품의 산제 투약 시 손실분의 분석과 개선 방안 병원약사회지, 2014, 제31권 6호, 1092-1098
    KCI후보 dColl.
  • 제2형 당뇨병 환자에서 시타글립틴과 메트포민 고정 복합제 투여와 단일제 병용간의 복약 순응도, 효과 및 약가에 대한 비교 연구 한국임상약학회지, 2014, 제24권 3호, 193-198
    KCI dColl.
  • 출생 체중 1 kg 미만의 초 극소 저 체중 출생아에서침습성 진균 감염증에 대한 Fluconazole 예방 요법의 효과 분석 병원약사회지, 2014, 제31권 4호, 919-927
    KCI후보 dColl.
  • [학술지논문] Health Behaviors Associated with Aggression in Korean Adolescents: Data from 2 Cross-sectional Studies AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2020, v.44 no.2 , 271-282
    SSCI
강의
  • 2024-2학기

    • 약물치료학Ⅰ 강의 계획서 상세보기

      • 학수번호 36215분반 01
      • 4학년 ( 3학점 , 3시간) 수 2~2 (약A104) , 목 5~5 (포551)
      • 전공필수 학번 1-40
    • 약물치료학Ⅰ 강의 계획서 상세보기

      • 학수번호 36215분반 02
      • 4학년 ( 3학점 , 3시간) 수 3~3 (약A104) , 금 4~4 (약A104)
      • 전공필수 학번 41-80
    • 약물치료학Ⅰ 강의 계획서 상세보기

      • 학수번호 36215분반 03
      • 4학년 ( 3학점 , 3시간) 목 2~2 (약A100-1) , 금 3~3 (약A104)
      • 전공필수 학번 81-120
    • 임상연구 설계 및 연구방법론

      • 학수번호 AP529분반 01
      • 학년 ( 3학점 , 3시간)
      • 원격강의
    • 임상연구 설계 및 연구방법론 강의 계획서 상세보기

      • 학수번호 CP529분반 01
      • 학년 ( 3학점 , 3시간) 월 8~9 (포451)
  • 2024-1학기

    • 약물치료학Ⅱ 강의 계획서 상세보기

      • 학수번호 37135분반 01
      • 5학년 ( 3학점 , 3시간) 월 5~5 (약A104) , 수 5~5 (약A404)
      • 전공필수,언어변경 학번 1~40
    • 약물치료학Ⅱ 강의 계획서 상세보기

      • 학수번호 37135분반 02
      • 5학년 ( 3학점 , 3시간) 월 3~3 (약A100-1) , 목 3~3 (약A404)
      • 전공필수,언어변경 학번 41~80
    • 약물치료학Ⅱ 강의 계획서 상세보기

      • 학수번호 37135분반 03
      • 5학년 ( 3학점 , 3시간) 화 3~3 (포552) , 목 5~5 (약A100-1)
      • 전공필수,언어변경 학번 81-120
    • 문헌평가및임상연구디자인 강의 계획서 상세보기

      • 학수번호 37139분반 01
      • 5학년 ( 1.5학점 , 1.5시간) 목 2~2 (약A404)
    • 병원실무실습II

      • 학수번호 37151분반 01
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 02
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 03
      • 6학년 ( 4학점 , 200시간)
      • 전공필수 산업제약학과 37151-06 반과 합반
    • 병원실무실습II

      • 학수번호 37151분반 04
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 05
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 06
      • 6학년 ( 4학점 , 200시간)
      • 전공필수 약학과 37151-03반과 합반
    • Honors research

      • 학수번호 37803분반 01
      • 4학년 ( 1학점 , 1시간)
    • 순환기 및 호흡기질환의 약물치료

      • 학수번호 AP531분반 01
      • 학년 ( 3학점 , 3시간)
      • 원격강의
    • 임상약물동태학/임상약물유전체학

      • 학수번호 AP650분반 01
      • 학년 ( 3학점 , 3시간)
      • 원격강의
    • 순환기 및 호흡기질환의 약물치료 강의 계획서 상세보기

      • 학수번호 CP531분반 01
      • 학년 ( 3학점 , 3시간) 월 8~9 (포451)
    • 임상약물동태학/임상약물유전체학 강의 계획서 상세보기

      • 학수번호 CP650분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (포451)
  • 2023-2학기

  • 2023-1학기

  • 2022-2학기

    • 약물치료학Ⅰ

      • 학수번호 36215분반 01
      • 4학년 ( 3학점 , 3시간) 화 3~3 (약A104) , 금 3~3 (약A104)
      • 전공필수 학번 1-43
    • 약물치료학Ⅰ

      • 학수번호 36215분반 02
      • 4학년 ( 3학점 , 3시간) 월 2~2 (약A404) , 목 5~5 (약A104)
      • 전공필수 학번 44-86
    • 약물치료학Ⅰ

      • 학수번호 36215분반 03
      • 4학년 ( 3학점 , 3시간) 수 4~4 (약A404) , 금 4~4 (약A104)
      • 전공필수 학번 87-130, 산업제약학과 04반과 합반
    • 약물치료학Ⅰ

      • 학수번호 36215분반 04
      • 4학년 ( 3학점 , 3시간) 수 4~4 (약A404) , 금 4~4 (약A104)
      • 전공필수 약학과 03반과 합반
    • 심화실습및연구Ⅱ

      • 학수번호 37155분반 01
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • Honors research

      • 학수번호 37803분반 01
      • 4학년 ( 1학점 , 1시간)
      • 팀티칭, 산업제약학과 02반과 합반
    • 임상연구설계및문헌평가

      • 학수번호 G16904분반 01
      • 학년 ( 3학점 , 3시간) 월 5~6 (약)
    • 임상연구 설계 및 연구방법론

      • 학수번호 CP529분반 01
      • 학년 ( 3학점 , 3시간) 월 8~9 (캠)
  • 2022-1학기

    • 1학년세미나(약대)

      • 학수번호 11401분반 02
      • 1학년 ( 1학점 월 7~7
      • 과학기술 인문학 / 장소: 교수연구실(약B103호)
    • 약물치료학Ⅱ

      • 학수번호 37135분반 01
      • 5학년 ( 3학점 , 3시간) 월 4~4 , 수 4~4
      • 전공필수,영어강의 팀티칭(1-43번)
    • 약물치료학Ⅱ

      • 학수번호 37135분반 02
      • 5학년 ( 3학점 , 3시간) 월 5~5 , 수 5~5
      • 전공필수,영어강의 팀티칭(44~86번)
    • 약물치료학Ⅱ

      • 학수번호 37135분반 03
      • 5학년 ( 3학점 , 3시간) 화 4~4 , 목 3~3
      • 전공필수,영어강의 팀티칭(87~130번) /산업제약학과 04반과 합반
    • 약물치료학Ⅱ

      • 학수번호 37135분반 04
      • 5학년 ( 3학점 , 3시간) 화 4~4 , 목 3~3
      • 전공필수,영어강의 추가개설/약학과 03반과 합반
    • 문헌평가및임상연구디자인

      • 학수번호 37139분반 01
      • 5학년 ( 1.5학점 , 1.5시간) 화 6~6
      • 산업제약학과 02반과 합반
    • 문헌평가및임상연구디자인

      • 학수번호 37139분반 02
      • 5학년 ( 1.5학점 , 1.5시간) 화 6~6
      • 추가개설/약학과 01반과 합반
    • 병원실무실습II

      • 학수번호 37151분반 01
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 02
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 03
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 04
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 05
      • 6학년 ( 4학점 , 200시간)
      • 전공필수
    • Honors research

      • 학수번호 37803분반 01
      • 4학년 ( 1학점 , 1시간)
      • 산업제약학과 02반과 합반
    • 신약개발세미나및실습III

      • 학수번호 G16849분반 01
      • 학년 ( 3학점 , 3시간) 목 7~8
    • 신약개발세미나및실습Ⅲ

      • 학수번호 G18240분반 01
      • 학년 ( 3학점 , 3시간) 목 7~8
    • 순환기 및 호흡기질환의 약물치료

      • 학수번호 CP531분반 01
      • 학년 ( 3학점 , 3시간) 월 8~9 (캠)
    • 임상약물동태학/임상약물유전체학

      • 학수번호 CP650분반 01
      • 학년 ( 3학점 , 3시간) 화 8~9 (캠)
  • 2021-2학기

    • 약물치료학Ⅰ

      • 학수번호 36215분반 01
      • 4학년 ( 3학점 , 3시간) 화 3~3 , 금 3~3
      • 전공필수 학번 1-43
    • 약물치료학Ⅰ

      • 학수번호 36215분반 02
      • 4학년 ( 3학점 , 3시간) 화 4~4 , 목 5~5
      • 전공필수 학번 44-86
    • 약물치료학Ⅰ

      • 학수번호 36215분반 03
      • 4학년 ( 3학점 , 3시간) 수 4~4 , 금 4~4
      • 전공필수 학번 87-130, 산업제약학과 04반과 합반
    • 약물치료학Ⅰ

      • 학수번호 36215분반 04
      • 4학년 ( 3학점 , 3시간) 수 4~4 , 금 4~4
      • 전공필수 약학과 03반과 합반
    • 심화실습및연구Ⅰ

      • 학수번호 37154분반 01
      • 6학년 ( 4학점
      • 전공필수
    • Honors research

      • 학수번호 37803분반 01
      • 4학년 ( 1학점 , 1시간)
      • 산업제약학과 02분반과 합반
    • 임상연구설계및문헌평가

      • 학수번호 G16904분반 01
      • 학년 ( 3학점 , 3시간) 수 5~6 (약)
    • 임상연구 설계 및 연구방법론

      • 학수번호 CP529분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
    • 임상연구 설계 및 연구방법론

      • 학수번호 CP529분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
    • 임상연구 설계 및 연구방법론

      • 학수번호 CP529분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
    • 임상연구 설계 및 연구방법론

      • 학수번호 CP529분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
  • 2021-1학기

    • 약물치료학Ⅱ

      • 학수번호 37135분반 01
      • 5학년 ( 3학점 , 3시간) 화 2~2 , 금 3~3
      • 전공필수,영어강의 팀티칭(1-43번)
    • 약물치료학Ⅱ

      • 학수번호 37135분반 02
      • 5학년 ( 3학점 , 3시간) 월 4~4 , 수 2~2
      • 전공필수,영어강의 팀티칭(44~86번)
    • 약물치료학Ⅱ

      • 학수번호 37135분반 03
      • 5학년 ( 3학점 , 3시간) 화 3~3 , 목 4~4
      • 전공필수,영어강의 팀티칭(87~130번)
    • 문헌평가및임상연구디자인

      • 학수번호 37139분반 01
      • 5학년 ( 1.5학점 , 1.5시간) 수 3~3
    • 병원실무실습II

      • 학수번호 37151분반 01
      • 6학년 ( 4학점
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 02
      • 6학년 ( 4학점 , 0시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 03
      • 6학년 ( 4학점 , 0시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 04
      • 6학년 ( 4학점 , 0시간)
      • 전공필수
    • 병원실무실습II

      • 학수번호 37151분반 05
      • 6학년 ( 4학점 , 0시간)
      • 전공필수
    • Honors research

      • 학수번호 37803분반 01
      • 4학년 ( 1학점 , 1시간)
      • 산업제약학과 02반과 합반
    • 순환계및내분비계질환의임상약료학

      • 학수번호 G16865분반 01
      • 학년 ( 3학점 , 3시간) 목 5~6
    • 내분비/소화기 약물요법

      • 학수번호 CP539분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
    • 내분비/소화기 약물요법

      • 학수번호 CP539분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
    • 내분비/소화기 약물요법

      • 학수번호 CP539분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
    • 내분비/소화기 약물요법

      • 학수번호 CP539분반 01
      • 학년 ( 3학점 , 3시간) 수 8~9 (캠)
학력

The University of Iowa Pharm.D.(약학과)